Last reviewed · How we verify

NCT06209983

The Effect of Enhanced Recovery After Surgery (ERAS) in Gastric Cancer Surgery

Active, enrolled NA Last updated 28 February 2024
What this trial tests

NA trial testing ERAS in Anesthesiology in 38 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
5 December 2018
Primary endpoint
31 December 2027
31 December 2027

Quick facts

Lead sponsorNational Taiwan University Hospital
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment38
Start date5 December 2018
Primary completion31 December 2027
Estimated completion31 December 2027
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 80, any sex, with Anesthesiology or General Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aimed to clarify the clinical relevance of the ERAS protocol by evaluating the perioperative course in patients undergoing laparoscopic gastric cancer surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ERAS

Trials testing the same drug.

Other recruiting trials for Anesthesiology

Currently open trials in the same condition.

Other National Taiwan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06209983.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing